Cargando…

Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line

Mutations in LRRK2 and GBA1 are key contributors to genetic risk of developing Parkinson’s disease (PD). To investigate how LRRK2 kinase activity interacts with GBA and contributes to lysosomal dysfunctions associated with the pathology of PD. The activity of the lysosomal enzyme β-Glucocerebrosidas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruz, Clara, Alcantud, José Luis, Vives, Francisco, Arrebola, Francisco, Hardy, John, Lewis, Patrick A., Manzoni, Claudia, Duran, Raquel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266636/ https://www.ncbi.nlm.nih.gov/pubmed/35805938 http://dx.doi.org/10.3390/ijms23136935

Ejemplares similares

Lysosomal Pathogenesis of Parkinson’s Disease: Insights From LRRK2 and GBA1 Rodent Models
por: Volta, Mattia
Publicado: (2022)

Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome
por: Ruz, Clara, et al.
Publicado: (2022)

Proteotoxicity and Neurodegenerative Diseases
por: Ruz, Clara, et al.
Publicado: (2020)

LRRK2 Kinase Inhibition Rescues Deficits in Lysosome Function Due to Heterozygous GBA1 Expression in Human iPSC-Derived Neurons
por: Sanyal, Anwesha, et al.
Publicado: (2020)

Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
por: Thaler, Avner, et al.
Publicado: (2021)

The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
por: Pradas, Eddie, et al.
Publicado: (2023)

Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use?
por: Roopnarain, Karisha, et al.
Publicado: (2023)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
por: Labrador-Garrido, Adahir, et al.
Publicado: (2023)

LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease
por: Pang, Shirley Yin-Yu, et al.
Publicado: (2022)

Turnover of C99 is Controlled by a Crosstalk between ERAD and Ubiquitin-Independent Lysosomal Degradation in Human Neuroglioma Cells
por: Bustamante, Hianara A., et al.
Publicado: (2013)

Lysosomal positioning regulates Rab10 phosphorylation at LRRK2(+) lysosomes
por: Kluss, Jillian H., et al.
Publicado: (2022)

Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson’s disease
por: Thaler, Avner, et al.
Publicado: (2020)

Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression
por: Ortega, Roberto A., et al.
Publicado: (2021)

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers
por: Droby, Amgad, et al.
Publicado: (2022)

Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
por: Smith, Laura J., et al.
Publicado: (2022)

“LRRK2: Autophagy and Lysosomal Activity”
por: Madureira, Marta, et al.
Publicado: (2020)

Novel Variants in LRRK2 and GBA Identified in Latino Parkinson Disease Cohort Enriched for Caribbean Origin
por: Nuytemans, Karen, et al.
Publicado: (2020)

LRRK2 at the interface of autophagosomes, endosomes and lysosomes
por: Roosen, Dorien A., et al.
Publicado: (2016)

Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies
por: Moors, Tim E., et al.
Publicado: (2018)

Role of Lysosomal Gene Variants in Modulating GBA ‐Associated Parkinson's Disease Risk
por: Straniero, Letizia, et al.
Publicado: (2022)

Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvation()
por: Manzoni, Claudia, et al.
Publicado: (2013)

Inhibition of LRRK2 kinase activity stimulates macroautophagy()
por: Manzoni, Claudia, et al.
Publicado: (2013)

miRNA-1271 inhibits cell proliferation in neuroglioma by targeting fibronectin 1
por: Gong, Jian, et al.
Publicado: (2017)

INHIBITION OF PACLITAXEL AGAINST NEUROGLIOMA CELLS U251 GROWTH AND ITS MECHANISM
por: Xin, ShiMeng, et al.
Publicado: (2016)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
por: Merchant, Kalpana M., et al.
Publicado: (2023)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
por: Tang, Yuting, et al.
Publicado: (2023)

Assaying the Kinase Activity of LRRK2 in vitro
por: Lewis, Patrick A.
Publicado: (2012)

LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients
por: Ysselstein, Daniel, et al.
Publicado: (2019)

The LRRK2 signalling system
por: Price, Alice, et al.
Publicado: (2018)

Pogostemon cablin as ROS Scavenger in Oxidant-induced Cell Death of Human Neuroglioma Cells
por: Kim, Hyung Woo, et al.
Publicado: (2010)

Patients treatment with neuroglioma by teniposide and semustine and its influence on Twist and E-cadherin expression
por: Zhang, Yongbo, et al.
Publicado: (2016)

LRRK2 mediates tubulation and vesicle sorting from lysosomes
por: Bonet-Ponce, Luis, et al.
Publicado: (2020)

Status of Emergency Department Seventy-Two Hour Return Visits Among Homeless Patients
por: Knowles, Heidi, et al.
Publicado: (2019)

Seventy-two-hour Return Initiative: Improving Emergency Department Discharge to Decrease Returns
por: Navanandan, Nidhya, et al.
Publicado: (2020)

Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease
por: Kim, Soojin, et al.
Publicado: (2021)

Computational analysis of the LRRK2 interactome
por: Manzoni, Claudia, et al.
Publicado: (2015)

Tolstoi in the Seventies /
por: Ėĭkhenbaum, B. (Boris), 1886-1959
Publicado: (1982)

Mesenchymal stromal cells attenuate sevoflurane-induced apoptosis in human neuroglioma H4 cells
por: Cheng, Yanyong, et al.
Publicado: (2018)

Seventy-two Hours, Targeting Time from First COVID-19 Symptom Onset to Hospitalization
por: Na, Baeg Ju, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7iq3l1j41gmjr5s5p74e659mvi